Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. PNTG
stocks logo

PNTG

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
276.57M
+46.41%
0.317
+31.95%
280.50M
+33.67%
0.302
+12.04%
284.95M
+29.82%
0.325
+20.37%
Estimates Revision
The market is revising Upward the revenue expectations for The Pennant Group, Inc. (PNTG) for FY2025, with the revenue forecasts being adjusted by 6.31% over the past three months. During the same period, the stock price has changed by 19.14%.
Revenue Estimates for FY2025
Revise Upward
up Image
+6.31%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+1.95%
In Past 3 Month
Stock Price
Go Up
up Image
+19.14%
In Past 3 Month
Wall Street analysts forecast PNTG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PNTG is 33.00 USD with a low forecast of 28.00 USD and a high forecast of 39.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Analyst Rating
Wall Street analysts forecast PNTG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PNTG is 33.00 USD with a low forecast of 28.00 USD and a high forecast of 39.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Buy
1 Hold
0 Sell
Strong Buy
Current: 28.940
sliders
Low
28.00
Averages
33.00
High
39.00
Current: 28.940
sliders
Low
28.00
Averages
33.00
High
39.00
Truist
Hold
to
Buy
upgrade
$34
2025-12-02
New
Reason
Truist
Price Target
$34
2025-12-02
New
upgrade
Hold
to
Buy
Reason
Truist upgraded Pennant Group to Buy from Hold with a $34 price target.
Truist
David MacDonald
Hold
to
Buy
upgrade
$28 -> $34
2025-12-02
New
Reason
Truist
David MacDonald
Price Target
$28 -> $34
2025-12-02
New
upgrade
Hold
to
Buy
Reason
Truist analyst David MacDonald upgraded Pennant Group to Buy from Hold with a price target of $34, up from $28. The upgrade reflects confidence in the company's complementary business model, solid sector trends, favorable reimbursement outlook after a better-than-expected 2026 Home Health Final Rule, and strong M&A momentum highlighted by the Amedisys deal, the analyst tells investors in a research note. Financial flexibility remains solid, and the valuation is viewed as offering an attractive risk-reward profile, the firm says.
Wells Fargo
Stephen Baxter
Equal Weight -> Overweight
upgrade
$29 -> $31
2025-11-18
Reason
Wells Fargo
Stephen Baxter
Price Target
$29 -> $31
2025-11-18
upgrade
Equal Weight -> Overweight
Reason
Wells Fargo analyst Stephen Baxter upgraded Pennant Group to Overweight from Equal Weight with a price target of $31, up from $29.
Wells Fargo
Stephen Baxter
Equal Weight -> Overweight
upgrade
$29 -> $31
2025-11-18
Reason
Wells Fargo
Stephen Baxter
Price Target
$29 -> $31
2025-11-18
upgrade
Equal Weight -> Overweight
Reason
Wells Fargo analyst Stephen Baxter upgraded Pennant Group to Overweight from Equal Weight with a price target of $31, up from $29. The firm sees upside in the stock even with conservative home health reimbursement rate assumptions. Materially improved reimbursement rates provide a a "nearly free" call option at current valuation levels, the analyst tells investors in a research note. Wells says the worse than expected proposed rule for 2026 home health rates has been an overhang on Pennant shares.
RBC Capital
Outperform
maintain
$34 -> $39
2025-11-17
Reason
RBC Capital
Price Target
$34 -> $39
2025-11-17
maintain
Outperform
Reason
RBC Capital raised the firm's price target on Pennant Group to $39 from $34 and keeps an Outperform rating on the shares. The Amedisys asset acquisition is likely underappreciated by the market, the analyst tells investors in a research note.
Jefferies
Brian Tanquilut
Buy
initiated
$30
2025-10-24
Reason
Jefferies
Brian Tanquilut
Price Target
$30
2025-10-24
initiated
Buy
Reason
Jefferies analyst Brian Tanquilut initiated coverage of Pennant Group with a Buy rating and $30 price target. The firm is bullish on the home health, saying the sector is a share gainer given its low-cost nature and patient preference for this site of care. As investors seek ways to play this thesis, Pennant sticks out given its low-teens EBITDA growth, driven by industry tailwinds and solid execution, the analyst tells investors in a research note.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Pennant Group Inc (PNTG.O) is 22.49, compared to its 5-year average forward P/E of 29.89. For a more detailed relative valuation and DCF analysis to assess Pennant Group Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PE
29.89
Current PE
22.49
Overvalued PE
50.46
Undervalued PE
9.31

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
21.24
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
32.99
Undervalued EV/EBITDA
9.48

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
1.26
Current PS
0.00
Overvalued PS
2.05
Undervalued PS
0.46
AI Stock Picker
AI Stock Picker

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Financial AI Agent
Financial AI Agent

PNTG News & Events

Events Timeline

(ET)
2025-12-01
10:00:00
Wells Fargo: 1.3% Rate Cut for Home Health in 2026, Positive for PNTG and BTSG
select
2025-12-01
09:50:00
CMS Finalizes 2026 Home Health Payment Policy with $405M Increase
select
link
2025-12-01
09:50:00
Wells Fargo: 5.1% Improvement in 2026 Home Health Rate Update
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
2.0
12-02Yahoo Finance
The Pennant Group (PNTG) Sees Stock Increase: Here's the Reason Why

  • Stock Performance: Shares of The Pennant Group rose 4.5% following a positive consensus 'Buy' rating from analysts, with a potential upside of over 22% based on an average price target of $34.33.

  • Market Sentiment: The stock's rise was influenced by comments from New York Federal Reserve President John Williams, which increased expectations for an interest rate cut, boosting market confidence amid high valuations in AI stocks.

[object Object]
Preview
4.0
11-19NASDAQ.COM
Wells Fargo Raises Rating on Pennant Group (PNTG)

  • Wells Fargo Upgrade: On November 18, 2025, Wells Fargo upgraded Pennant Group's outlook from Equal-Weight to Overweight, with an average one-year price target of $34.00/share, indicating a potential upside of 33.86% from its closing price of $25.40/share.

  • Institutional Ownership Trends: There are 401 funds reporting positions in Pennant Group, reflecting a 7.22% increase in ownership over the last quarter, with total shares owned by institutions rising by 2.79% to 35,470K shares.

  • Fund Sentiment: The put/call ratio for Pennant Group is 0.92, suggesting a bullish sentiment among investors, while several firms have adjusted their portfolio allocations, with some increasing and others decreasing their holdings.

  • Projected Financials: The projected annual revenue for Pennant Group is estimated at $550 million, representing a decrease of 35.06%, with a projected non-GAAP EPS of 0.98.

[object Object]
Preview
9.5
11-06NASDAQ.COM
The Pennant Group, Inc. (PNTG) Exceeds Q3 Earnings and Revenue Projections

  • Earnings Performance: The Pennant Group, Inc. reported quarterly earnings of $0.30 per share, exceeding the Zacks Consensus Estimate of $0.29, and showing an increase from $0.26 per share a year ago. The company has surpassed consensus EPS estimates three out of the last four quarters.

  • Revenue Growth: The company generated revenues of $229.04 million for the quarter, surpassing the Zacks Consensus Estimate by 2.71% and up from $180.69 million year-over-year. It has also topped revenue estimates in all four of the last quarters.

  • Stock Outlook: Despite the positive earnings report, The Pennant Group's shares have declined by 4.7% since the start of the year, underperforming the S&P 500's 15.1% gain. The stock currently holds a Zacks Rank #3 (Hold), indicating expected performance in line with the market.

  • Industry Context: The Medical - Outpatient and Home Healthcare industry, to which The Pennant Group belongs, is currently ranked in the top 18% of Zacks industries, suggesting a favorable outlook. Investors are advised to monitor earnings estimate revisions for future performance insights.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Pennant Group Inc (PNTG) stock price today?

The current price of PNTG is 28.94 USD — it has decreased -0.48 % in the last trading day.

arrow icon

What is Pennant Group Inc (PNTG)'s business?

The Pennant Group, Inc. is a holding company of independent operating subsidiaries that provide healthcare services through home health and hospice agencies and senior living communities located throughout Arizona, California, Colorado, Connecticut, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, Wyoming, Tennessee, Georgia and Alabama. Each of these businesses is operated by a separate, independent operating subsidiary. Its segments include home health and hospice services, and senior living services. Its home health and hospice services segment includes its home health, hospice and home care businesses. Its home health services provide care after surgery or when illness or health conditions require additional assistance. Its senior living services segment includes the operation of assisted living, independent living and memory care communities. Its independent living communities are designed for active individuals or couples.

arrow icon

What is the price predicton of PNTG Stock?

Wall Street analysts forecast PNTG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PNTG is 33.00 USD with a low forecast of 28.00 USD and a high forecast of 39.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Pennant Group Inc (PNTG)'s revenue for the last quarter?

Pennant Group Inc revenue for the last quarter amounts to 229.04M USD, increased 26.76 % YoY.

arrow icon

What is Pennant Group Inc (PNTG)'s earnings per share (EPS) for the last quarter?

Pennant Group Inc. EPS for the last quarter amounts to 0.17 USD, decreased -15.00 % YoY.

arrow icon

What changes have occurred in the market's expectations for Pennant Group Inc (PNTG)'s fundamentals?

The market is revising Upward the revenue expectations for The Pennant Group, Inc. (PNTG) for FY2025, with the revenue forecasts being adjusted by 6.31% over the past three months. During the same period, the stock price has changed by 19.14%.
arrow icon

How many employees does Pennant Group Inc (PNTG). have?

Pennant Group Inc (PNTG) has 7000 emplpoyees as of December 05 2025.

arrow icon

What is Pennant Group Inc (PNTG) market cap?

Today PNTG has the market capitalization of 1,000M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free